North American Brain Tumor Consortium

Field Hierarchy

Parent
Phase i study 0 papers	Disease free survival 0 papers	Progression-free survival 22.4k papers	Temozolomide 17.1k papers
Maximum tolerated dose 1,790 papers
Current
North American Brain Tumor Consortium papers
Child

Trends

Notes

History